About Us

Since 2016, Weill Cornell Medicine (New York) and the Gustave Roussy Cancer Campus (Paris) have joined forces to organize an annual conference that provides a forum for education, discussion, and networking among investigators interested in developing safe and effective RT-IT combinations (ImmunoRad).

Contact Info

Email
christine.corinus

Phone
+33 (0) 1 42 11 53 22

  Gustave Roussy Cancer Campus,
Research Department
Pièce 65 - B2M

 

Select your language

Poster session

ImmunoRad Paris 2025

Jérôme Galon

Cordeliers Research Center, France

 

Specialized in the fields of immunology and cancer, Jérôme Galon is Research Director at INSERM (French NIH), and head of the laboratory of Integrative Cancer Immunology, in Paris, France. He is associate Director and co-founder of European Academy of Tumor Immunology (EATI), board member of Society for Immunotherapy of Cancer (SITC). His work on the comprehensive analysis of the tumor-microenvironment and the role of T-cells in human cancer led to the demonstration of the importance of adaptive pre-existing immunity in human cancer, and the concept of cancer immune-contexture. He pioneered the Immunoscore. He is the co-founder of HalioDx company and the Chairman of its scientific council. His contributions have been recognized with numerous awards, including the William B. Coley Award, an international prize which honors the best scientists in the fundamental and cancer immunology, and Award from the National Academy of Science, and Award from the National Academy of Medicine.